Business Standard

Stock valuations factor in negatives for ICICI Lombard, say analysts

Improving topline growth but combined ratio, loss ratio key concerns

ICICI Lombard
Premium

The retail health growth was moderate but satisfactory at 16 per cent compared with 47 per cent growth in the group health segment

Devangshu Datta
The Q2 results of ICICI Lombard General Insurance Company drew mixed reactions from analysts though the market responded with selling down the share. The net profit beat expectations but that was partly due to tax reversal, which meant a credit of Rs 130 crore.
 
Growth momentum in the commercial segment and in group health insurance compensated for weakness in the core motor insurance business and moderate growth in retail health. The combined ratio remains high due to a strategy of disruptive pricing to cope with competition and also investments in growth.
 
The general insurer has lost market share in the

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 19 2022 | 11:22 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com